Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Responding to Efficacy Decay Analysis of Artemisinin Based Combination Therapy (ACTs) in Rural Tanzania: Intervening on Provider Compliance and Patient Adherence to Correct Malaria Treatment

NCT02298140 is registered in ClinicalTrials.gov with Ifakara Health Institute as lead sponsor.

NCT NCT02298140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02298140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Responding to Efficacy Decay Analysis of Artemisinin Based Combination Therapy (ACTs) in Rural Tanzania: Intervening on Provider Compliance and Patient Adherence to Correct Malaria Treatment
Lead sponsor
Ifakara Health Institute
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2015
Enrollment
712 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria